Annual EBITDA
$3.45B$197.00M+6.05%
Summary
- Current Value
- As of today, IQV annual EBITDA is $3.45B, up +6.05% on
- Historical Performance
- IQV annual EBITDA is up +24.79% over the past 3 years, and up +72.56% over the past 5 years
- All-Time High Comparison
- IQV annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- IQV annual EBITDA is +18.70% above its 3-year low of $2.91B reached on an earlier date
- Sector Comparison
- IQV annual EBITDA is higher than 97.28% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.45B | +6.0% | +24.8% | +72.6% | +638.8% | |
| Quarterly EBITDA | $858.00M | +0.6% | +19.8% | +61.9% | – | |
| TTM EBITDA | $3.39B | +2.9% | +15.1% | +73.2% | – | |
| Price | $241.40 | +17.4% | +8.0% | +28.6% | – | |
| PE Ratio | 33.14 | +20.8% | -15.3% | -74.8% | – | |
| Annual Revenue | $15.41B | +3.0% | +11.0% | +38.9% | +292.6% | |
| Annual EPS | $7.49 | +2.7% | +51.1% | +682.4% | +500.9% | |
| Annual EBIT | $2.34B | +9.8% | +55.6% | +192.7% | +510.4% | |
| Annual Net Income | $1.37B | +1.1% | +41.4% | +504.9% | +730.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.45B | at high | |
| 5Y | $3.45B | at high | |
| All | $3.45B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.91B | N/A | +18.7% |
| 5Y | $2.08B | N/A | +66.3% |
| All | $385.74M | +795.1% |
EBITDA History
FAQ
What is the current annual EBITDA of IQV?
As of today, IQV annual EBITDA is $3.45B
What is 1-year change in IQV annual EBITDA?
IQV annual EBITDA is up +6.05% year-over-year
What is 3-year change in IQV annual EBITDA?
IQV annual EBITDA is up +24.79% over the past 3 years
How far is IQV annual EBITDA from its all-time high?
IQV annual EBITDA is currently at its all-time high
How does IQV annual EBITDA rank versus sector peers?
IQV annual EBITDA is higher than 97.28% of companies in Healthcare sector
When is IQV next annual earnings release?
The next annual earnings release for IQV is on
Quarterly EBITDA
$858.00M$46.00M+5.67%
Summary
- Current Value
- As of today, IQV quarterly EBITDA is $858.00M, up +5.67% on
- Historical Performance
- IQV quarterly EBITDA is up +0.59% year-over-year, and up +19.83% over the past 3 years
- All-Time High Comparison
- IQV quarterly EBITDA is currently -7.24% below its historical high of $925.00M set on
- 3-Year Low Comparison
- IQV quarterly EBITDA is +18.51% above its 3-year low of $724.00M reached on
- Sector Comparison
- IQV quarterly EBITDA is higher than 96.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $858.00M | +5.7% | +0.6% | +19.8% | +61.9% | |
| Annual EBITDA | $3.45B | – | +6.0% | +24.8% | +72.6% | |
| TTM EBITDA | $3.39B | +0.1% | +2.9% | +15.1% | +73.2% | |
| Price | $241.40 | +10.4% | +17.4% | +8.0% | +28.6% | |
| PE Ratio | 33.14 | +10.4% | +20.8% | -15.3% | -74.8% | |
| Quarterly Revenue | $4.10B | +2.1% | +5.3% | +15.3% | +46.9% | |
| Quarterly EPS | $1.93 | +25.5% | +24.6% | +29.0% | +272.0% | |
| Quarterly EBIT | $573.00M | +6.9% | -0.3% | +22.4% | +171.6% | |
| Quarterly Net Income | $332.00M | +24.8% | +16.5% | +17.3% | +207.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $925.00M | N/A | -7.2% |
| 3Y | $925.00M | -7.2% | |
| 5Y | $925.00M | -7.2% | |
| All | $925.00M | -7.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $792.00M | +8.3% | |
| 3Y | $724.00M | +18.5% | |
| 5Y | $625.00M | N/A | +37.3% |
| All | $118.10M | +626.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of IQV?
As of today, IQV quarterly EBITDA is $858.00M
What is IQV quarterly EBITDA most recent change?
IQV quarterly EBITDA was up +5.67% on September 30, 2025
What is 1-year change in IQV quarterly EBITDA?
IQV quarterly EBITDA is up +0.59% year-over-year
How far is IQV quarterly EBITDA from its all-time high?
IQV quarterly EBITDA is currently -7.24% below its historical high of $925.00M set on December 31, 2024
How does IQV quarterly EBITDA rank versus sector peers?
IQV quarterly EBITDA is higher than 96.47% of companies in Healthcare sector
When is IQV next earnings release?
The next earnings release for IQV is on
TTM EBITDA
$3.39B$5.00M+0.15%
Summary
- Current Value
- As of today, IQV TTM EBITDA is $3.39B, up +0.15% on
- Historical Performance
- IQV TTM EBITDA is up +2.92% year-over-year, and up +15.13% over the past 3 years
- All-Time High Comparison
- IQV TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- IQV TTM EBITDA is +15.40% above its 3-year low of $2.94B reached on
- Sector Comparison
- IQV TTM EBITDA is higher than 96.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.39B | +0.1% | +2.9% | +15.1% | +73.2% | |
| Annual EBITDA | $3.45B | – | +6.0% | +24.8% | +72.6% | |
| Quarterly EBITDA | $858.00M | +5.7% | +0.6% | +19.8% | +61.9% | |
| Price | $241.40 | +10.4% | +17.4% | +8.0% | +28.6% | |
| PE Ratio | 33.14 | +10.4% | +20.8% | -15.3% | -74.8% | |
| TTM Revenue | $15.90B | +1.3% | +3.9% | +11.1% | +45.0% | |
| TTM EPS | $7.28 | +5.5% | -4.5% | +18.5% | +711.3% | |
| TTM EBIT | $2.26B | -0.1% | +4.3% | +18.4% | +223.0% | |
| TTM Net Income | $1.28B | +3.8% | -8.6% | +8.6% | +548.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.39B | at high | |
| 3Y | $3.39B | at high | |
| 5Y | $3.39B | at high | |
| All | $3.39B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.38B | +0.1% | |
| 3Y | $2.94B | +15.4% | |
| 5Y | $2.07B | N/A | +63.7% |
| All | $118.10M | +2767.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of IQV?
As of today, IQV TTM EBITDA is $3.39B
What is IQV TTM EBITDA most recent change?
IQV TTM EBITDA was up +0.15% on September 30, 2025
What is 1-year change in IQV TTM EBITDA?
IQV TTM EBITDA is up +2.92% year-over-year
How far is IQV TTM EBITDA from its all-time high?
IQV TTM EBITDA is currently at its all-time high
How does IQV TTM EBITDA rank versus sector peers?
IQV TTM EBITDA is higher than 96.56% of companies in Healthcare sector
When is IQV next earnings release?
The next earnings release for IQV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- IQV Official Website www.iqvia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1478242/000162828025046794/0001628280-25-046794-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478242/000147824225000045/0001478242-25-000045-index.htm
- IQV Profile on Yahoo Finance finance.yahoo.com/quote/IQV
- IQV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iqv